Anika Therapeutics
ANIK
$27.59
Share price
4.15%
Change (1 day)
6.12%
Change (1 year)
Categories
Operating Margin for Anika Therapeutics (ANIK)
Operating Margin as of May 2024 (TTM): 1.64%
According to Anika Therapeutics's latest financial reports and stock price the company's current Operating Margin is 1.64%. At the end of 2021 the company had an Operating Margin of 1.64%.
Operating Margin history for Anika Therapeutics from 2001 to 2022
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2021 | 1.64% | -107.48% |
| 2020 | -21.94% | -169.62% |
| 2019 | 31.52% | 43.35% |
| 2018 | 21.99% | -46.03% |
| 2017 | 40.74% | -17.22% |
| 2016 | 49.21% | -5.16% |
| 2015 | 51.89% | -10.92% |
| 2014 | 58.25% | 34.64% |
| 2013 | 43.26% | 58.08% |
| 2012 | 27.37% | 28.59% |
| 2011 | 21.28% | 61% |
| 2010 | 13.22% | -3.76% |
| 2009 | 13.73% | 4% |
| 2008 | 13.21% | -53.14% |
| 2007 | 28.18% | 0.47% |
| 2006 | 28.05% | -14.54% |
| 2005 | 32.82% | 28.17% |
| 2004 | 25.61% | 433.75% |
| 2003 | 4.80% | -120.84% |
| 2002 | -23.02% | -61.42% |
| 2001 | -59.66% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | 22.88% | 1,295.12% | 🇺🇸 USA |
 Medtronic MDT | 17.17% | 946.95% | 🇮🇪 Ireland |
 Stryker Corporation SYK | 16.21% | 888.41% | 🇺🇸 USA |
 STAAR Surgical STAA | 16.10% | 881.71% | 🇺🇸 USA |
 Halozyme Therapeutics HALO | 37.47% | 2,184.76% | 🇺🇸 USA |
 Hill-Rom HRC | 12.20% | 644.14% | 🇺🇸 USA |
What is a company's Operating Margin
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.